Fate Therapeutics Inc.

Fate Therapeutics Inc.

Biotechnology Research

San Diego, California 22,034 followers

Transforming the lives of patients with cancer and autoimmune diseases.

About us

Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company’s effector cell pipeline includes multiplexed-engineered, iPSC-derived natural killer (NK) cell and T-cell product candidates, which incorporate novel synthetic controls of cell function, such as chimeric antigen receptors (CARs) to target tumor-associated antigens and are intended to deliver multiple mechanisms of therapeutic importance to patients including in combination with well-established cancer therapies. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
San Diego, California
Type
Public Company
Founded
2007
Specialties
stem cells, stem cell modulators, iPS cells, iPSCs, T Cells, NK Cells, CAR T, Cell Therapy, Pluripotent Stem Cells, Off-the-Shelf, autoimmune disorders, and immuno-oncology

Locations

  • Primary

    12278 Scripps Summit Dr

    San Diego, California 92131, US

    Get directions

Employees at Fate Therapeutics Inc.

Updates

Similar pages

Browse jobs

Funding

Fate Therapeutics Inc. 17 total rounds

Last Round

Post IPO equity

US$ 100.0M

See more info on crunchbase